Expect prior-auth friction, but NEJM-level separation strengthens the case for patients aiming for higher loss thresholds or struggling to reach 10% on current therapy
Covington P., Christopher R., Davenport M., et al., Pharmacokinetic, Pharmacodynamic, and Tolerability Profiles of the Dipeptidyl Peptidase4 Inhibitor Alogliptin: A Randomized, DoubleBlind, PlaceboControlled, MultipleDose Study in Adult Patients With Type 2 Diabetes, Clinical Therapeutics 30, no
Both forms work identically and share the same mechanism of action
Depending on the patients condition, doctors may focus on managing vascular risk factors, monitoring the affected and unaffected eye, and evaluating possible interventions on a case-by-case basis such as prescribing medication such as corticosteroids (e.g., prednisone) to reduce inflammation and improve blood flow to the optic nerve, anticoagulants (e.g., aspirin) to help prevent blood clots that could block blood flow to the optic nerve and angiogenesis inhibitors (e.g., bevacizumab) to try to block the growth of abnormal blood vessels that can damage the optic nerve
If you're focusing too much on protein, you might miss out on other nutrients, such as fiber
11 References About Peptide Therapy Peptide therapy is a minimally invasive treatment designed to help improve various health and wellness concerns
